Innovation Talk - Digitalization & automation in Bio- and Pharma production
The ability of biopharmaceutical manufacturers to deliver high-quality products even in times of difficult market conditions is crucial to ensuring long-term sustainability. The COVID 19 pandemic has highlighted the need for the traditional biopharmaceutical supply chain to focus more on agility and resilience to successfully navigate market fluctuations and volatile times. Manufacturers need to consider innovative solutions to meet increased demands and manage increasing complexity using proven technologies, as well as establish digitised/automated production to achieve new levels of operational excellence through digital transformation, leading to a more powerful modern value chain.
The growth of biotech companies and start-ups plays a key role in future innovation and product development in the life science industry in Denmark. Furthermore, a strong biotech sector and good framework conditions for commercialisation are crucial for Denmark. New technologies are still being introduced on a regular basis in the biotech market worldwide, and all large companies as well as innovative SMEs are constantly looking for potential partners. Therefore, it is crucial for companies to build networks and establish contacts with potential business partners.
Monday, 27 June 2022, 10:00-13:00 CEST
An agenda in English can be found here.
Please register for the event here. Participation is free of charge.
Contact at BayFOR
Dr. Mikhail Antonkin (Antonkine),
Ph.D. in Biochemistry, Microbiology, Molecular Biology
Scientific Officer Health Research & Biotechnology
Phone: +49 911 50715-950